Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019064082) PHARMACEUTICAL ABUSE DETERRENT COMPOSITION CONSTRUCTED IN MORE THAN ONE STRENGTHS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/064082 International Application No.: PCT/IB2018/054443
Publication Date: 04.04.2019 International Filing Date: 16.06.2018
IPC:
A61K 9/16 (2006.01) ,A61K 47/32 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
14
Particulate form, e.g. powders
16
Agglomerates; Granulates; Microbeadlets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
32
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
Applicants:
PATEL, Jayendrakumar Dasharathlal [IN/IN]; IN
Inventors:
PATEL, Jayendrakumar Dasharathlal; IN
Priority Data:
20172103483801.10.2017IN
Title (EN) PHARMACEUTICAL ABUSE DETERRENT COMPOSITION CONSTRUCTED IN MORE THAN ONE STRENGTHS
(FR) COMPOSITION PHARMACEUTIQUE ANTI-ABUS PRÉPARÉE EN PLUS D'UNE CONCENTRATION
Abstract:
(EN) A pharmaceutical abuse deterrent composition and method of making the same is described in the present invention. A pharmaceutical abuse deterrent composition is constructed in one strength or more than one strength, wherein each strength in alone or in combination with another strength has a unique overdose prevention features. A pharmaceutical abuse deterrent composition is constructed in one strength or more than one strength, wherein each strength has resistant to physical tampering and chemical tampering.
(FR) L'invention concerne une composition pharmaceutique anti-abus et son procédé de fabrication. Une composition pharmaceutique anti-abus est préparée en une concentration ou plus d'une concentration, chaque concentration seule ou en combinaison avec une autre concentration ayant des caractéristiques uniques de prévention de surdose. Une composition pharmaceutique anti-abus est préparée en une résistance ou plus d'une résistance, chaque résistance ayant une résistance à l'altération physique et à l'altération chimique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)